CM
VERA icon

Caption Management’s Vera Therapeutics VERA Stock Holding History

Caption Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-135,800
Closed -$3.26M – 1929
2025
Q1 		$3.26M Buy
+135,800
New +$4.36M 0.03% 525
2024
Q2 		– Sell
-32,500
Closed -$1.4M – 1533
2024
Q1 		$1.4M Buy
+32,500
New +$1.16M 0.02% 652

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Caption Management's VERA Position: Q2 2025 in Review

Caption Management sold out of Vera Therapeutics (VERA) in Q2 2025, closing a stake of 44,052 shares — an estimated $991K sold.

Caption Management first reported a position in VERA in Q1 2024 and held it in 2 quarters. The position peaked at $1.06M in Q1 2025. 172 funds tracked by Wall St. Rank hold VERA as of Q2 2025.

  • Caption Management reported no remaining Vera Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 44,052 Vera Therapeutics shares in Q2 2025, an estimated $991K.
  • Caption Management first reported a position in Vera Therapeutics in Q1 2024 and held it in 2 quarters.
  • Caption Management's Vera Therapeutics position peaked at $1.06M in Q1 2025.
  • 172 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.